Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma

British Journal of Cancer

Volumn 108, Issue 2, 2013, Pages 387-394

  Choi, Y ^a   Park, B ^b   Kim, K ^a   Jeong, B C ^b   Seo, S I ^b   Jeon, S S ^b   Choi, H Y ^b   Lee, J E ^a   Lee, H M ^b  

^a Sookmyung Women's University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Anaemia; Erythrocyte sedimentation rate; Prognostic biomarkers; Renal cell carcinoma; Survival

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BODY MASS; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CLINICAL EVALUATION; COHORT ANALYSIS; DEATH; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HISTOLOGY; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL NEPHRECTOMY; PREDICTOR VARIABLE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SAMPLE SIZE; SURVIVAL PREDICTION;

AGED; ALKALINE PHOSPHATASE; ANEMIA; BLOOD SEDIMENTATION; BODY MASS INDEX; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84873736157     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.565     Document Type: Article

References (28)

1. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc Ser B (Method) 57: 289-300.
2. Brigden ML (1999) Clinical utility of the erythrocyte sedimentation rate. Am Fam Physician 60: 1443-1450. (Pubitemid 29498209)
3. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27: 612-624. (Pubitemid 36514472)
4. Choi Y, Park B, Jeong B, Seo S, Jeon S, Choi H, Adami H, Lee J, Lee H (2012) Body mass index and survival in patients with renal cell carcinoma: A clinical-based cohort and meta-analysis. Int J Cancer 132(3): 625-634.
5. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis 30: 1073-1081.
6. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420: 860-867. (Pubitemid 36019639)
7. Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6: 655-663. (Pubitemid 13234762)
8. Hockel M, Vaupel P (2001) Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93: 266-276. (Pubitemid 32219813)
9. Jensen HK, Donskov F, Marcussen N, Nordsmark M, Lundbeck F, von der Maase H (2009) Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J Clin Oncol 27: 4709-4717.
10. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Seo HG, Lee JS (2012) Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 44: 11-24.
11. Kaplan MM (1972) Alkaline phosphatase. N Engl J Med 286: 200-202.
12. Kim HL, Belldegrun AS, Freitas DG, Bui MH, Han KR, Dorey FJ, Figlin RA (2003) Paraneoplastic signs and symptoms of renal cell carcinoma: Implications for prognosis. J Urol 170: 1742-1746. (Pubitemid 37254919)
13. Korean National Statistical Office (2010) Annual Report on the Cause of Death Statistics (Based on Vital Registration). pp 254 Korean National Statistical Office: Daejeon. Korean National Statistical Office (1995) Korea Standard Classification of Cause of Death (KCD). 3rd revisionKorean National Statistical Office: Seoul.
14. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, Storkel S, van den Berg E, Zbar B (1997) The Heidelberg classification of renal cell tumours. J Pathol 183: 131-133.
15. Kume H, Kakutani S, Yamada Y, Shinohara M, Tominaga T, Suzuki M, Fujimura T, Fukuhara H, Enomoto Y, NishimatsüH, Homma Y (2011) Prognostic factors for renal cell carcinoma with bone metastasis: Who are the long-term survivors? J Urol 185: 1611-1614.
16. Laski ME, Vugrin D (1987) Paraneoplastic syndromes in hypernephroma. Semin Nephrol 7: 123-130.
17. Lee SE, Byun SS, Han JH, Han BK, Hong SK (2006) Prognostic significance of common preoperative laboratory variables in clear cell renal cell carcinoma. BJÜInt 98: 1228-1232. (Pubitemid 44721231)
18. Littlewood TJ (2001) The impact of hemoglobin levels on treatment outcomes in patients with cancer. Semin Oncol 28: 49-53. (Pubitemid 32522238)
19. Magera Jr JS, Leibovich BC, Lohse CM, Sengupta S, Cheville JC, Kwon ED, Blute ML (2008) Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell renal cell carcinoma. Urology 71: 278-282. (Pubitemid 351282342)
20. Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J (1999) Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 17: 2530-2540. (Pubitemid 29368255)
21. Presti JC Jr, Rao PH, Chen Q, Reuter VE, Li FP, Fair WR, Jhanwar SC (1991) Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res 51: 1544-1552.
22. Sengupta S, Lohse CM, Cheville JC, Leibovich BC, Thompson RH, Webster WS, Frank I, Zincke H, Blute ML, Kwon ED (2006) The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma. Cancer 106: 304-312. (Pubitemid 43100438)
23. Srigley JR, Hutter RV, Gelb AB, Henson DE, Kenney G, King BF, Raziuddin S, Pisansky TM (1997) Current prognostic factors-renal cell carcinoma: Workgroup No. 4. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80: 994-996.
24. Steering Committee of the Western Pacific Region of the World Health Organization, the International Association for the Study of Obesity, the International Obesity Task Force (2000) The Asia-Pacific perspective: Redefining obesity and its treatment. Health Communications Australia Pty Limited.
25. Stolbach LL, Krant MJ, Fishman WH (1969) Ectopic production of an alkaline phosphatase isoenzyme in patients with cancer. N Engl J Med 281: 757-762.
26. Sufrin G, Chasan S, Golio A, Murphy GP (1989) Paraneoplastic and serologic syndromes of renal adenocarcinoma. Semin Urol 7: 158-171.
27. World Health Organization (1992) International Classifications of Diseases and Related Health Problems: Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. 10th edWorld Health Organization: Geneva.
28. WüY, FüX, ZhüX, He X, ZoüC, Han Y, XüM, Huang C, LüX, Zhao Y (2011) Prognostic role of systemic inflammatory response in renal cell carcinoma: A systematic review and meta-analysis. J Cancer Res Clin Oncol 137: 887-896.